- LIFE SCIENCES STRATEGY · DEVELOPMENT · GROWTH
Building Value Across Life Sciences.
We align science, strategy, and execution around the milestones that matter.
Science-led thinking. Business-minded execution.
CONNECTED BY SCIENCE. DRIVEN BY VALUE.
How We Help
We help biotech and emerging pharmaceutical companies advance promising assets in the U.S. We also help life science service and technology providers build stronger, more valuable businesses.
WHO WE SERVE
Two pathways. One focus on meaningful value.
ONE CONNECTED PERSPECTIVE
Strategy
Clarify the opportunity and define the path forward.
Development
Organize expertise and execution around key milestones.
Growth
Build stronger positioning, capabilities, and strategic value.
Why Us
Bringing together the expertise, resources, and execution to move you forward.
value

Multidisciplinary Industry Expertise
Clinical, regulatory, AI & data science, commercial and business expertise.

Lean, Senior Teams
Fit-for-purpose teams combining senior internal resources with specialized industry experts.

We Invest and Lead the Team
Focused capital and hands-on execution aligned around defined milestones and outcomes.

Development + Business Perspective
Drug-development and partnering expertise connecting development decisions with strategic opportunities.

Defined Value-Creation Milestones
We focus on clinical, regulatory and commercial milestones that strengthen assets, growth and enterprise value.
PERSPECTIVES FOR PROGRESS
Featured Insights

Why Clinical Development Strategy Should Begin Before IND Submission
IND submission is one of the most visible milestones in early drug development. But treating the IND as the starting

Where AI Can Actually Create Value in Clinical Development
Artificial intelligence is rapidly becoming part of clinical development. But adoption alone does not create value. For sponsors, the more

Global Business Expansion: Why the U.S. Is the Top Choice
Did you know that foreign companies held over $5.39 trillion in direct investments in the U.S. by the end of